BRIEF published on 07/29/2024 at 08:34, 1 year 4 months ago New paragon Lead Plant Inaugurated in China Automotive Industry Electromobility Paragon AG Kunshan Plant China Expansion
PRESS RELEASE published on 07/29/2024 at 08:29, 1 year 4 months ago New paragon lead plant inaugurated in China paragon GmbH & Co. KGaA inaugurates new lead plant in Kunshan, China, expanding production and office space. The modern facility strengthens partnerships with Chinese car manufacturers Automotive Industry China Paragon GmbH Lead Plant Kunshan
BRIEF published on 07/25/2024 at 08:12, 1 year 4 months ago Paragon Announces Preliminary Half-Year Figures - Operating Profitability and Cash Flow Improved EBITDA Cash Flow Profitability Half-year Results Paragon
PRESS RELEASE published on 07/25/2024 at 08:07, 1 year 4 months ago paragon announces preliminary half-year figures - operating profitability and cash flow improved paragon GmbH & Co. KGaA announces preliminary half-year figures with improved operating profitability and cash flow. Earnings and EBITDA ratios show growth despite sales decline EBITDA Cash Flow Profitability Half-year Results Paragon GmbH
BRIEF published on 05/07/2024 at 07:35, 1 year 6 months ago Paragon GmbH Reports Strong Start to 2024 Despite Challenges Revenue Forecast EBITDA Growth Q1 2024 Financial Results Paragon GmbH Operational Expansion
PRESS RELEASE published on 05/07/2024 at 07:30, 1 year 6 months ago paragon enters the new year with optimism - positive start to 2024 paragon GmbH & Co. KGaA starts 2024 optimistically with positive revenue and EBITDA growth. Company confirms forecast for the year EBITDA Revenue Growth Paragon GmbH & Co. KGaA Forecast Confirmation 2024 Financial Results
BRIEF published on 04/25/2024 at 08:05, 1 year 7 months ago Paragon AG Releases 2023 Annual Financial Report, Confirms Forecast EBITDA Paragon GmbH & Co. KGaA Debt Reduction Financial Results 2023 2024 Forecast
PRESS RELEASE published on 04/25/2024 at 08:00, 1 year 7 months ago Audited consolidated financial statements for 2023 confirm communicated forecast paragon GmbH & Co. KGaA's audited consolidated financial statements for 2023 confirm communicated forecast of stable sales and improved earnings. Debt reduction and positive outlook for 2024 highlighted 2024 Outlook Forecast Paragon GmbH & Co. KGaA Debt Reduction Audited Financial Statements
PRESS RELEASE published on 01/26/2024 at 15:24, 1 year 10 months ago paragon founder bundles shares in family holding paragon founder Klaus Dieter Frers transfers 49.3% shares to Frers Family Office GmbH, making it the largest shareholder, exempted from mandatory offer by BaFin. paragon GmbH & Co. KGaA is a global supplier to the automotive industry. Paragon GmbH & Co. KGaA Klaus Dieter Frers Frers Family Office GmbH Shareholder Structure BaFin Exemption
PRESS RELEASE published on 10/26/2023 at 16:01, 2 years 1 month ago paragon launches bond buyback programme
Published on 12/05/2025 at 02:35, 5 hours 26 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 7 hours 1 minute ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 56 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 1 minute ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 1 hour 1 minute ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 31 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 8 hours 10 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 36 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 46 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 14 hours 1 minute ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 16 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 14 hours 17 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 1 hour ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 14 hours ago Declaration of voting rights at the end of November 2025
